Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07535268 · ClinicalTrials.gov registry record
REPRESENT-PF Registry
A clinical trial, sponsored by Vivek Reddy.
- Recruiting
- Registry status
- 275
- Enrollment target
NCT07535268 is a clinical trial that is actively recruiting participants, run by Vivek Reddy. The registered enrollment target is 275 participants.
The verdict
NCT07535268 is actively recruiting participants, sponsored by Vivek Reddy.
- RECRUITING
- Registry status
- 275 participants
- Enrollment target
Study Summary
This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
Interventions
- DEVICE FARAWAVE Pulsed Field Ablation Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2026-03-30 |
| Est. Completion | 2028-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07535268
The ClinicalTrials.gov registry entry for NCT07535268 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FARAWAVE Pulsed Field Ablation Catheter is the first listed.
NCT07535268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07535268 about?
NCT07535268 is a clinical study titled "REPRESENT-PF Registry". This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of ca...
What is the current status of trial NCT07535268?
This trial is currently recruiting. The enrollment target is 275 participants. The study started on 2026-03-30. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07535268?
The interventions under investigation include: FARAWAVE Pulsed Field Ablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT07535268?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.